Design and Rationale for a Randomized, Double-Blind, Placebo-Controlled Phase 2/3 Trial of Oral Arimoclomol in Inclusion Body Myositis
RRNMF Neuromuscular Journal（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined